The Mycoplasma Hominis RNA Detection Qualitative Test is a specialized diagnostic procedure designed to identify the presence of Mycoplasma hominis, a bacterium associated with various infections in humans, particularly in the genitourinary tract. This test specifically targets the RNA sequences of the bacterium, providing a qualitative assessment, which means it indicates whether or not the RNA of Mycoplasma hominis is present in the sample, without quantifying the amount.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced diagnostic solutions, this test employs sophisticated molecular techniques to ensure high sensitivity and specificity. The test is crucial for diagnosing infections caused by Mycoplasma hominis, which can lead to pelvic inflammatory disease, postpartum fever, and other reproductive issues. Early detection through this RNA-based test can significantly improve the management and treatment outcomes for affected individuals.
The cost of the Mycoplasma Hominis RNA Detection Qualitative Test at DNA Labs UAE is set at 1190 AED. This price reflects the advanced technology and expertise required to accurately detect the presence of Mycoplasma hominis RNA, contributing to the timely diagnosis and treatment of infections caused by this bacterium. Patients seeking this test can expect professional service and reliable results from DNA Labs UAE, making it a valuable resource for healthcare providers and individuals concerned about Mycoplasma hominis infections.
The "Large Biopsy 2-All Cancer Resection Test" offered by DNA Labs UAE is a comprehensive diagnostic procedure aimed at detecting and analyzing cancerous tissues in the body. This test involves the removal of a large tissue sample from a tumor or a suspicious area that might be cancerous. The primary goal is to determine the presence, type, and extent of cancer, aiding in the formulation of an effective treatment plan.
Performed by skilled medical professionals, this biopsy test is critical for the accurate diagnosis of various types of cancers. It allows pathologists to examine the tissue under a microscope, looking for cancer cells and providing vital information about the cancer's grade and stage.
The cost of the "Large Biopsy 2-All Cancer Resection Test" at DNA Labs UAE is set at 1050 AED. This price reflects the intricate nature of the procedure and the sophisticated laboratory analyses required to deliver precise and reliable results. Patients undergoing this test at DNA Labs UAE can expect state-of-the-art facilities and cutting-edge technology, ensuring high-quality diagnostic services.
This test is crucial for anyone who has been identified with potential cancerous growths, as it provides essential insights that guide treatment decisions. With its comprehensive approach to cancer diagnosis, the "Large Biopsy 2-All Cancer Resection Test" is a key step in the journey towards effective cancer management and treatment.
The "MAFIgH MM Test" offered at DNA Labs UAE is a specialized medical examination designed to assess specific health markers or genetic conditions. With a test cost of 1050 AED, this analysis provides valuable insights into the patient's medical status, aiding in the diagnosis, treatment planning, or risk assessment for certain diseases. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability in results, leveraging advanced technology and expert analysis. Patients seeking comprehensive health evaluations can consider the MAFIgH MM Test as part of their proactive health management strategy.
The Del5q Myelodysplastic Syndrome (MDS) Test is a specialized diagnostic procedure aimed at detecting the deletion of a portion of the long arm (q arm) of chromosome 5. This specific chromosomal abnormality is associated with a subtype of Myelodysplastic Syndromes, a group of bone marrow disorders characterized by the production of insufficient and defective blood cells. Identifying the Del5q abnormality is crucial for the diagnosis, prognosis, and treatment planning of patients with MDS.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs sophisticated technologies to analyze the genetic material of cells obtained from a blood or bone marrow sample. The accuracy and reliability of the results make it a valuable tool for hematologists and oncologists in managing MDS.
The cost of the Del5q MDS Test at DNA Labs UAE is 1050 AED. Considering the complexity of the analysis and the insights it provides into the patient's condition, the test represents a significant step forward in personalized medicine, enabling targeted therapeutic strategies for individuals with this chromosomal deletion.
The "Del7q MDS Test" refers to a diagnostic examination specifically designed to detect deletions on the long arm (q arm) of chromosome 7, associated with Myelodysplastic Syndromes (MDS). Myelodysplastic Syndromes are a group of disorders caused by poorly formed or dysfunctional blood cells, often leading to anemia and other hematological issues. The deletion of part of chromosome 7 (del(7q)) is a significant genetic abnormality linked to MDS, which can influence disease prognosis and treatment strategies.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to identify the presence of the del(7q) mutation. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals specialized in genetic and molecular diagnostics, ensuring high accuracy and reliability of test results.
The cost of the Del7q MDS Test at DNA Labs UAE is set at 1050 AED. This price reflects the comprehensive approach taken by the lab, including the use of advanced testing methodologies, analysis by qualified personnel, and the provision of detailed results that can guide therapeutic decisions. For patients suspected of having MDS or for those being monitored for changes in their disease status, this test offers critical insights that can significantly impact their management and treatment plans.
The "Del11qATM MM CLL Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM). This test specifically looks for deletions on chromosome 11q, which includes the ATM gene, a mutation associated with a more aggressive form of these cancers and can significantly impact treatment decisions and prognosis. The deletion of the ATM gene is an important prognostic marker in CLL and MM, as it can affect the patient's response to certain therapies and overall survival rates. By identifying this genetic abnormality early, clinicians can tailor treatment strategies more effectively to improve outcomes. The test is priced at 1050 AED, reflecting the specialized technology and expertise required to accurately detect these chromosomal deletions. DNA Labs UAE is known for its state-of-the-art facilities and commitment to providing precise and timely diagnostic services, making it a trusted choice for patients and healthcare providers seeking comprehensive genetic testing options.
The Del13q MM CLL Test is a specialized genetic test performed at DNA Labs UAE, aimed at detecting the deletion of chromosome 13q, which is a common genetic abnormality associated with multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). This test is crucial for the diagnosis, prognosis, and management of patients with these hematological malignancies. By identifying the deletion of chromosome 13q, healthcare providers can better understand the disease's behavior, predict treatment responses, and tailor therapeutic strategies accordingly.
The test is conducted using advanced molecular techniques to analyze the patient's DNA for the specific deletion. It is a valuable tool in the personalized medicine approach, helping in stratifying patients according to their genetic risk and guiding decision-making regarding their treatment.
The cost of the Del13q MM CLL Test at DNA Labs UAE is set at 1050 AED. This price reflects the comprehensive nature of the test, including the sophisticated laboratory analysis and the expertise required to accurately interpret the results. Patients seeking this test can expect a reliable service that contributes significantly to the effective management of multiple myeloma and chronic lymphocytic leukemia.
The "Del17p/p53 MM CLL Test" is a specialized diagnostic test offered by DNA Labs UAE, designed to detect deletions in chromosome 17p, which includes the TP53 gene, in patients with multiple myeloma (MM) or chronic lymphocytic leukemia (CLL). These genetic abnormalities are associated with a more aggressive disease course and poorer prognosis. Identifying patients with these mutations can significantly influence treatment decisions and strategies, as they may not respond well to certain therapies and might benefit from more aggressive or alternative treatments.
The test cost is 1050 AED and involves collecting a blood or bone marrow sample from the patient, which is then analyzed using advanced genetic testing techniques to identify the presence of the del17p mutation and alterations in the p53 gene. The results from this test provide critical information that helps healthcare providers tailor treatment plans to the specific genetic profile of the patient's disease, aiming for more effective management and improved outcomes.
DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art facilities and employs highly skilled professionals to ensure accurate and reliable testing services. This test represents an important tool in the precision medicine approach to treating hematologic malignancies, highlighting the role of genetic insights in optimizing patient care.
The Delta Beta-Thalassaemia Mutation Screening Test is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations associated with Delta Beta-Thalassemia, a rare blood disorder. This condition results from deletions or mutations in the delta and beta globin genes, leading to reduced or absent production of the delta and beta globin chains, components crucial for hemoglobin formation. Hemoglobin is the protein in red blood cells responsible for oxygen transport throughout the body. Abnormalities in its structure can lead to various health issues, including anemia, fatigue, and more severe complications if left undiagnosed or untreated.
The screening test is crucial for early detection, allowing for appropriate management and counseling for affected individuals and their families. It involves collecting a blood sample from the patient, which is then analyzed using advanced molecular techniques to identify specific genetic mutations associated with the condition.
DNA Labs UAE offers this important test at a cost of 1050 AED. The lab is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and analysis, ensuring accurate and reliable results. Early detection through the Delta Beta-Thalassaemia Mutation Screening Test can significantly improve the quality of life for individuals with the condition by enabling tailored treatments and interventions.
DiGeorge Syndrome FISH (Fluorescence In Situ Hybridization) Test is a specialized diagnostic procedure designed to identify DiGeorge Syndrome, a genetic disorder caused by the deletion of a segment of chromosome 22. This condition can lead to a wide range of developmental issues, including heart defects, immune system problems, and facial abnormalities. The FISH test is a powerful tool that enables precise detection of the genetic anomaly associated with DiGeorge Syndrome by using fluorescent probes that bind to specific parts of the chromosome to highlight the presence or absence of genetic material.
At DNA Labs UAE, the DiGeorge Syndrome FISH Test is available for patients who may exhibit symptoms of the syndrome or have a family history suggesting a genetic risk. The test cost is set at 1050 AED, reflecting the advanced technology and expertise required to conduct this sophisticated genetic analysis. The process involves collecting a sample of the patient's blood, which is then processed in the laboratory where the DNA is examined for the specific chromosomal deletion associated with the syndrome. Results from this test can provide crucial information for diagnosis, allowing healthcare providers to offer appropriate treatment and support for affected individuals and their families.
